- Report
- August 2025
- 194 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- August 2025
- 181 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 185 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- June 2026
- 184 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 188 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- June 2026
- 195 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 199 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 197 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 196 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 184 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 186 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 182 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 196 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- January 2026
- 183 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- June 2026
- 197 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- June 2026
- 196 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- June 2026
- 192 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- November 2025
- 184 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- October 2025
- 183 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP
- Report
- August 2025
- 183 Pages
Global
From €3211EUR$3,545USD£2,770GBP
€3568EUR$3,939USD£3,078GBP

The Vaccine Manufacturing market is a subset of the biopharmaceutical industry, which focuses on the development and production of vaccines. Vaccines are biological products that are used to prevent and treat infectious diseases. Vaccine manufacturing involves the production of active ingredients, such as antigens, as well as the formulation and packaging of the final product. Vaccine manufacturers must adhere to strict regulatory standards to ensure the safety and efficacy of their products.
The Vaccine Manufacturing market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more